Evidence map›Paper›PMID 41515472›Full record

ReviewMolecules (Basel, Switzerland)2026

Advances in Dysprosium Recovery from Secondary Sources: A Review of Hydrometallurgical, Biohydrometallurgical and Solvometallurgical Approaches.

Ewa Rudnik

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Ewa RudnikFaculty of Non-Ferrous Metals, AGH University of Krakow, Al. Mickiewicza 30, 30-059 Krakow, Poland.ORCID 0000-0002-7827-033X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysprosium is one of the most critical elements for global economies due to its essential role in the green energy transition. Although it is added in small quantities as an alloying element, dysprosium plays a crucial role in NdFeB magnets used in wind turbines and industrial motors. On the other hand, the limited resources and production capacity of dysprosium contribute to supply shortages and raise concerns about its long-term availability. Therefore, there is a need for efficient techniques that will enable the recovery of dysprosium from secondary materials to bridge the gap between supply and demand while addressing the risks associated with securing a stable supply. This review focuses on (bio)hydrometallurgical and solvometallurgical methods for recovering dysprosium from key secondary sources such as spent NdFeB magnets, phosphogypsum, and coal ash. Although these wastes do not always contain high concentrations of dysprosium, they can have a simpler elemental composition compared to primary sources (a few tens or hundreds of ppm Dy) and are more readily available. Spent NdFeB magnets, with a few percent Dy, show the most promise for recycling. In contrast, coal fly ashes (with several ppm Dy), although widely available, bind dysprosium in an inert phase, requiring substantial pretreatment to enhance the release of the desired element. Phosphogypsum, while not yet a significant source of dysprosium (several ppm Dy), is increasingly recognized as a potential source for other rare earth elements. Although conventional hydrometallurgical methods are commonly used, these are typically unselective for dysprosium recovery, whereas unconventional solvometallurgical approaches show preferential extraction of dysprosium over base metals.

Indexed as

coal ashdysprosiumleachingneodymium magnetsphosphogypsumseparation techniques

Identifiers

PMID41515472
PMCPMC12787622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.